These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1205616)

  • 21. [A new interferon inducer active via peroral administration].
    Ershov FI; Saĭitkulov AM; Tazulakhova EB; Sadykov AS
    Vopr Virusol; 1986; 31(3):335-8. PubMed ID: 2429451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement by muramyldipeptides of the activities of early-type inducers of interferon.
    Ikeda S; Matsuda Y; Nishimura C
    Antiviral Res; 1985 Dec; 5(6):345-53. PubMed ID: 2418780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feline interferon response to 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166).
    Stringfellow DA; Weed Sd
    Am J Vet Res; 1977 Dec; 38(12):1963-7. PubMed ID: 596695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced NK cell activity in mice injected with interferon and interferon inducers.
    Gidlund M; Orn A; Wigzell H; Senik A; Gresser I
    Nature; 1978 Jun; 273(5665):759-61. PubMed ID: 566386
    [No Abstract]   [Full Text] [Related]  

  • 25. Variation of interferon induction at the bone marrow level. Studies on interferon induction in relation to natural cell-mediated cytotoxic mechanisms.
    Orn A; Gidlund M; Wigzell H; Gresser I
    Eur J Immunol; 1981 Oct; 11(10):795-9. PubMed ID: 6171433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of acid-stable canine interferon in vivo and in vitro.
    Forman MS; Adams EW; Vanderpool EA; Turner W
    Am J Vet Res; 1979 Oct; 40(10):1440-2. PubMed ID: 43104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-interferon globulin inhibits macrophage phagocytic enhancement in vivo by tilorone or Newcastle disease virus.
    Rabinovitch M; Manejias RE
    Cell Immunol; 1978 Sep; 39(2):402-6. PubMed ID: 699064
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhancing effect of interferon pretreatment on interferon production.
    Ito F; Kobayashi S
    Jpn J Microbiol; 1974 May; 18(3):223-8. PubMed ID: 4372434
    [No Abstract]   [Full Text] [Related]  

  • 29. Mycoplasma-associated induction of interferon in ovine leukocytes.
    Rinaldo CR; Overall JC; Cole BC; Glasgow LA
    Infect Immun; 1973 Nov; 8(5):796-803. PubMed ID: 4356073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the interferons induced in mice in vivo and in macrophages in vitro by Newcastle disease virus and by polyinosinic-polycytidylic acid.
    Brehm G; Kirchner H
    J Interferon Res; 1986 Feb; 6(1):21-8. PubMed ID: 2422299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of interferon antiviral action in L-cells by cyclic nucleotides.
    Allen LB; Eagle NC; Huffman JH; Shuman DA; Meyer RB; Sidwell RW
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):580-4. PubMed ID: 4365315
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hyper- and hypo-reactivity in mice with regard to the induction of virus inhibitory factor or interferon].
    Nagano Y; Kimura K; Takano S
    C R Seances Soc Biol Fil; 1978; 172(4):809-13. PubMed ID: 154964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable response of normal and transformed mouse cells to interferon inducers.
    Treagan L; Jayne A; Prato C
    Acta Virol; 1976 Feb; 20(1):83-5. PubMed ID: 7948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of tumor growth rate by interferon inducers.
    Gazdar AF
    J Natl Cancer Inst; 1972 Nov; 49(5):1435-8. PubMed ID: 4346539
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhancement of interferon production in vitro: a property of tilorone-poly rL:rC/DEAE-Dextran.
    Groelke JW; Camyre KP; Mayer GD
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):1044-7. PubMed ID: 165541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of polynucleotide-induced hyporeactivity in mice treated with interferon and antitumor therapy.
    Imanishi J; Kita M; Sugino S; Oku T; Kishida T
    J Interferon Res; 1982; 2(1):65-74. PubMed ID: 6180107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production and initial characterization of guinea pig interferon.
    Warfel AH; Stewart WE
    J Interferon Res; 1980; 1(1):19-22. PubMed ID: 6180041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of hyporeactivity (tolerance) to a viral interferon inducer on the transplantation of Krebs 2 ascitic carcinoma cells in mice].
    Marchenko VI; Pokidysheva LN
    Vopr Virusol; 1974; (4):396-400. PubMed ID: 4439850
    [No Abstract]   [Full Text] [Related]  

  • 39. Interferon induction by lymphocytic choriomeningitis viruses correlates with maximum virulence.
    Jacobson S; Friedman RM; Pfau CJ
    J Gen Virol; 1981 Dec; 57(Pt 2):275-83. PubMed ID: 6172554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of N-acetyl-muramyl-L-alanyl-D-isoglutamine on interferon production in mice by Newcastle disease virus.
    Sakuma T; Azuma M; Yoshida I
    J Gen Virol; 1984 May; 65 ( Pt 5)():999-1003. PubMed ID: 6202835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.